430 – A Multicenter, Randomized, Double-Blind Study of Ulimorelin and Metoclopramide in the Treatment of Critically Ill Patients with Enteral Feeding Intolerance: Promote Trial

Purpose Enteral feeding intolerance (EFI) is a frequent problem in the intensive care unit (ICU), but current prokinetic agents have uncertain efficacy and safety profiles. The current study compared the efficacy and safety of ulimorelin, a ghrelin agonist, with metoclopramide in the treatment of EFI.